Real-World Data Reveals Vision Decline as Copay Programs End
A recent analysis confirms that losing copay assistance for retina treatments can worsen vision, as patients switch to alternatives or delay treatment.
The study, presented at the American Academy of Ophthalmology meeting, shows that low-income patients are particularly affected by underfunding of copay assistance.
Loss of copay assistance for retina treatments can worsen vision as they switch to alternatives or delay treatment.
- The research aimed to validate the findings of a survey by the American Society of Retina Specialists (ASRS) with real-world clinical evidence.
- The survey, presented at the ASRS meeting in August 2025, asked 455 retina specialists about adapting to the underfunding of the Good Days program.
Author's summary: Vision decline confirmed as copay programs end.
More News
- The Secret Lives of Mormon Wives Season 3 Trailer and Key Art
- More than 250 tickets issued to Cape Breton driver over Thanksgiving
- Work restarts on HS2 tunnels after safety shutdown
- Cape Breton Capers need three wins in four days to defend AUS women’s soccer championship at home
- Word on the Street: Could you live for a year on a space station? - Benton County Enterprise
- Acadia's Adams earns AUS community service award
- Change of position leads Cape Breton rugby player Brielynn Murrant to AUS most valuable player award
- Cape Breton Capers’ Piepgrass named AUS men’s soccer most valuable player, all-star teams announced